SpringWorks Therapeutics 배당금
배당금 기준 확인 0/6
SpringWorks Therapeutics does not have a record of paying a dividend.
주요 정보
n/a
배당 수익률
-13.3%
환매 수익률
| 총 주주 수익률 | -13.3% |
| 미래 배당 수익률 | 0% |
| 배당금 성장 | n/a |
| 다음 배당금 지급일 | n/a |
| 전 배당일 | n/a |
| 주당 배당금 | n/a |
| 지급 비율 | n/a |
최근 배당금 업데이트
업데이트 없음
Recent updates
SpringWorks Therapeutics Merits A Speculative Buy
Nov 04SpringWorks Therapeutics: Rising On A Strong Post-Launch Quarter, Now Justified As A Buy
Aug 07Need To Know: Analysts Are Much More Bullish On SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Revenues
May 11
We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth
May 03SpringWorks Therapeutics: Newly Commercial Stage, Fully Valued Biotech Means Steer Clear
Apr 25SpringWorks Therapeutics: Multiple Opportunities, But No Sure-Fire Winners
Apr 19We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth
Sep 20We're Not Very Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Rate
Jun 07We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth
Feb 22Here's Why We're Not Too Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation
Nov 09SpringWorks drops 21% as Allogene drops lead asset in combination study
Aug 10SpringWorks Therapeutics GAAP EPS of -$1.41 misses by $0.15
Aug 04Sizing Up SpringWorks Therapeutics
Jul 20Will SpringWorks Therapeutics (NASDAQ:SWTX) Spend Its Cash Wisely?
Jun 06SpringWorks Therapeutics: Rating Buy Ahead Of Mid-Year Data Releases
May 02Companies Like SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Invest In Growth
Dec 30SpringWorks Is A Biotech To Watch With Several Partnerships And Solid Drug Pipeline
Dec 14SpringWorks Therapeutics (NASDAQ:SWTX) Is In A Strong Position To Grow Its Business
Sep 15SpringWorks shows durable effect for neurofibroma therapy with long-term data
Jun 15SpringWorks teams up with Seagen to evaluate nirogacestat combo in multiple myeloma
Jun 07We're Interested To See How SpringWorks Therapeutics (NASDAQ:SWTX) Uses Its Cash Hoard To Grow
May 31SpringWorks Therapeutics EPS misses by $0.11
May 06결제의 안정성과 성장
배당금 데이터 가져오기
안정적인 배당: Insufficient data to determine if SWTX's dividends per share have been stable in the past.
배당금 증가: Insufficient data to determine if SWTX's dividend payments have been increasing.
시장 대비 배당 수익률
| SpringWorks Therapeutics 시장 대비 배당 수익률 |
|---|
| 세그먼트 | 배당 수익률 |
|---|---|
| 회사 (SWTX) | n/a |
| 시장 하위 25% (US) | 1.5% |
| 시장 상위 25% (US) | 4.5% |
| 업계 평균 (Biotechs) | 2.2% |
| 애널리스트 예측 (SWTX) (최대 3년) | 0% |
주목할만한 배당금: Unable to evaluate SWTX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
고배당: Unable to evaluate SWTX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
주주에 대한 수익 배당금
수익 보장: Insufficient data to calculate SWTX's payout ratio to determine if its dividend payments are covered by earnings.
주주에 대한 현금 배당금
현금 흐름 범위: Unable to calculate sustainability of dividends as SWTX has not reported any payouts.